Myeloma survival triples on new therapies; diagnosis lag persists

Advances in multiple myeloma treatment have tripled patient survival over recent decades, though non-specific symptoms still delay diagnosis, especially in older adults. The report highlights a medical progress story with a persistent clinical challenge, but no new data or policy shift is introduced.